Ascendia Pharmaceutical Solutions Launched to Meet Drug Development and Manufacturing Needs

– Leading Pharmaceutical CDMO, Formerly Ascendia Pharmaceuticals, Re-brands to Better Reflect Expanding Capabilities – NORTH BRUNSWICK, N.J., Dec. 9, 2024 /PRNewswire/ — Jim Huang, Ph.D., founder and CEO of Ascendia Pharmaceuticals, announces that the pharmaceutical contract development…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.